Enario, Noli P.
HRN: 23-75-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
MUPIROCIN 2%, 15G (TUBE)
04/02/2025
04/09/2025
TOPICAL
Apply Generously
TID
S/P Excision Of Nasoalveolar Mass Right Nostril
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes